BRIEF

on MediClin AG (ETR:MED)

MEDICLIN AG Reports Steady Growth in 2025

MEDICLIN AG announced its nine-month financial results for 2025, showing consistent progress in line with expectations. The company reported consolidated group sales of EUR 586.9 million, marking a 5.1% increase from the previous year. The group operating result rose to EUR 48.9 million from EUR 34.5 million in the same period of 2024. Capacity utilisation remained stable at 86.8%.

In the post-acute segment, sales grew by 9.3%, while the operating result was up by EUR 9.6 million. The acute segment, impacted by the sale of MEDICLIN Herzzentrum Coswig, showed a small decline in sales but managed an operating result improvement. The service segment saw a significant rise in its operating result, reaching EUR 1.0 million.

The Management Board projects group sales growth between 2.0% and 5.0% for the year and maintains confidence in reaching their annual targets.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MediClin AG news